What is SecondWave Systems?
SecondWave Systems is at the forefront of developing a groundbreaking, ultrasound-based wearable neuromodulation platform. This innovative technology aims to provide patients and their physicians with a new therapeutic option for managing debilitating or life-threatening diseases. The company's focus on non-invasive neuromodulation positions it within the rapidly expanding medtech sector, addressing critical unmet needs in patient care.
How much funding has SecondWave Systems raised?
SecondWave Systems has raised a total of $17.4M across 3 funding rounds:
Angel/Seed
$7.4M
Other Financing Round
$3M
Series A
$7M
Angel/Seed (2021): $7.4M with participation from U.S. Department of Defense and Department of Defense - Defense Advanced Research Projects Agency
Other Financing Round (2024): $3M led by Advanced Research Projects Agency for Health and Department of Defense - Defense Advanced Research Projects Agency
Series A (2025): $7M supported by Scientific Health Development, Treo Ventures, Sectoral Asset Management, and Carlson School of Management - University of Minnesota
Key Investors in SecondWave Systems
Advanced Research Projects Agency for Health
The Advanced Research Projects Agency for Health (ARPA-H) is a key backer, focused on driving high-impact research and delivering transformative health solutions. Their involvement signals a strong belief in SecondWave Systems' potential to create significant biomedical breakthroughs.
Scientific Health Development
Scientific Health Development is a venture capital firm specializing in early-stage medtech companies, indicating a strategic interest in SecondWave Systems' innovative approach to unmet clinical needs.
Treo Ventures
Treo Ventures, a capital fund focused on medical device and digital health innovation, has provided backing, aligning with SecondWave Systems' mission to address large unmet healthcare needs through advanced technology.
What's next for SecondWave Systems?
With the recent major strategic investment, SecondWave Systems is poised for significant expansion. The capital will likely be deployed to advance clinical trials, scale manufacturing capabilities, and broaden market access for its unique neuromodulation platform. The company's trajectory suggests a strong focus on translating its technological innovation into tangible patient benefits and commercial success, potentially leading to further growth phases or strategic partnerships within the healthcare industry.
See full SecondWave Systems company page
